Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Monotherapy with GLP-1 receptor agonist, lixisenatide, significantly improves glycaemic control in type 2 diabetic patients [abstract 830]
doi: 10.1126/science.abc8861
Common gastrointestinal effects include: Bloating and gas : Increased fermentation activity from probiotic bacteria can produce excess intestinal gas, causing abdominal distension and discomfort Mild diarrhea or loose stools : Changes in gut flora composition may temporarily alter bowel habits Abdominal cramping : Some individuals experience mild to moderate cramping as their digestive system adapts Nausea : Less common but reported, particularly when supplements are taken on an empty stomach These symptoms are generally mild, self-limiting, and often resolve within days to weeks as the microbiome equilibrates
BMC Womens Health , 14(1), 138
10.1148/radiology.188.1.8511313 104
Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
US$ 20.50
US$ 22.12
US$ 20.48
US$ 25.94
US$ 23.03
US$ 24.22
